JPRN-jRCT2080220516未知3 期
A multicenter investigative study of the safety and efficacy of long-term administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episode
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Trial subjects will be men and women of age 18 or above and below the age of 65 who will not be turning 65 during the trial.
- •-Patients who meet DSM-IV-TR criteria for manic or mixed episodes and have been diagnosed as having 296.4x Bipolar I Disorder in which the most recent episode was manic or 296.6x Bipolar I Disorder in which the most recent episode was mixed
- •-Patients with a YMRS total score of 16 or more
排除标准
- 未提供
研究者
相似试验
未知
3 期
A multicenter, investigative study of the safety and efficacy of extended administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episodeAcute manic and mixed episodes associated with Bipolar I DisorderJPRN-jRCT2080220515Otsuka Pharmaceutical Co., Ltd.
招募中
不适用
Prospective multicenter study regarding the safety of surgical results of laparoscopic pancreatic resection; Japanese Society for Endoscopic Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, and Japan Society for Endoscopic Surgery cooperative studyPancreatobiliary diseases (Patients planned to undergo laparoscopic pancreatic resection)JPRN-UMIN000022836Japanese Society for Endoscopic Pancreatic Surgery3,000
已完成
不适用
Multicenter Clinical Study Evaluating the Safety and Efficacy of Dasatinib Treatment and its Discontinuation in Patients with Chronic Phase Chronic Myelogenous Leukemia who had Reached Complete Molecular Response during Imatinib TherapyChronic Phase Chronic Myelogenous LeukemiaJPRN-UMIN000007221Juntendo University School of Medicine40
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 17.1Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2014-001971-30-ITovartis Farma SPA5,000
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioEUCTR2014-001971-30-FIovartis Pharma services AG5,000